Overview

The Asia Pacific interventional cardiology devices market was valued at USD 4,268.5 Million in 2020 and is expected to grow at a CAGR of 3.9% over the forecast period. The changing insurance coverage coupled with rising awareness about patient benefits is expected to drive the market during the forecast period. Countries like China and India is developing price control program for these medical devices. This trend is expected to contribute to slower growth of interventional cardiology devices market in the foreseeable future. Presence of end-to-end manufacturers that are engaged in providing value-added services for minimum profit margins is expected to bolster growth. Market by Type: Interventional Catheters, Stents, PTCA Guidewires, Balloon Inflation Device, and PTCA Balloons. Asia Pacific Market by Country: India, China, Japan, and South Korea.